Myelin Oligodendrocyte Glycoprotein Peptide 35-55

<strong>Myelin Oligodendrocyte Glycoprotein Peptide 35-55</strong>_x000D_ <strong>Catalog number:</strong> B2017471_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 250 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> MOG Peptide 35-55 Rat, Mouse_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Triantafyllakou I, Clemente N, Khetavat RK, Dianzani U, Tselios T. Development of PLGA Nanoparticles with a Glycosylated Myelin Oligodendrocyte Glycoprotein Epitope (MOG(35-55)) against Experimental Autoimmune Encephalomyelitis (EAE) Mol Pharm. 2022 Nov 7;19(11):3795-3805._x000D_ 2: Albouz-Abo S, Wilson JC, Bernard CC, von Itzstein M. A conformational study of the human and rat encephalitogenic myelin oligodendrocyte glycoprotein peptides 35-55 Eur J Biochem. 1997 May 15;246(1):59-70._x000D_ 3: Androutsou ME, Nteli A, Gkika A, Avloniti M, Dagkonaki A, Probert L, Tselios T, Golič Grdadolnik S. Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis Int J Mol Sci. 2020 Oct 13;21(20):7566._x000D_ 4: Oliver AR, Lyon GM, Ruddle NH. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice J Immunol. 2003 Jul 1;171(1):462-8._x000D_ 5: Bergman CM, Marta CB, Maric M, Pfeiffer SE, Cresswell P, Ruddle NH. A switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-γ-inducible lysosomal thiol reductase-free mice J Immunol. 2012 Jun 15;188(12):6001-9._x000D_ 6: Ntountaniotis D, Vanioti Μ, Kordopati GG, Kellici TF, Marousis KD, Mavromoustakos T, Spyroulias GA, Golic Grdadolnik S, Tselios TV. A combined NMR and molecular dynamics simulation study to determine the conformational properties of rat/mouse 35-55 myelin oligodendrocyte glycoprotein epitope implicated in the induction of experimental autoimmune encephalomyelitis J Biomol Struct Dyn. 2017 May;35(7):1559-1567._x000D_ 7: Ichikawa M, Koh CS, Inaba Y, Seki C, Inoue A, Itoh M, Ishihara Y, Bernard CC, Komiyama A. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice Cell Immunol. 1999 Feb 1;191(2):97-104._x000D_ 8: Klementiev B, Enevoldsen MN, Li S, Carlsson R, Liu Y, Issazadeh-Navikas S, Bock E, Berezin V. Antiinflammatory properties of a peptide derived from interleukin-4 Cytokine. 2013 Oct;64(1):112-21._x000D_ 9: Mony JT, Khorooshi R, Owens T. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE Mult Scler. 2014 Sep;20(10):1312-21._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/28369944">10: Chevalier AC, Rosenberger TA. Increasing acetyl-CoA metabolism attenuates injury and alters spinal cord lipid content in mice subjected to experimental autoimmune encephalomyelitis J Neurochem. 2017 Jun;141(5):721-737. </a>_x000D_ _x000D_ <strong>Products Related to Myelin Oligodendrocyte Glycoprotein Peptide 35-55 can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>